It would make a lot of sense now that IMU is having CAR-T as one of its pipelines. CHM's Brain Cancer and NK-cell technologies are both close to start their registrational trials, that would mean in 2025 IMU could have 4 Rego trials. Imagine, if all 4 would be approved in 2026 / 2027.
CHM is atm valued worthless, but the GBM CAR-T is atm the most advanced GBM treatment - Imagine that! Then they are doing an NK-Cell AML trial in the US, approached by MD Anderson Texas due to fantastic ph 1 / 2 results. Again, CHM valued worthless.
Plus they got the green light to start the first ever direct attacking solid cancer CAR-T based on CD 17. That alone is more worth than $ ZERO.
And Hopper holds 19.99% of CHM. A t/o at 20c, about 200m EV, would make him a bit richer too. And me too, LOL.
GLTA
It would make a lot of sense now that IMU is having CAR-T as one...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $505.0M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.1¢ | 6.8¢ | $1.427M | 20.55M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 57517 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 667419 | 9 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
0.000 ( 0.29 %) |
||||
| Open | High | Low | Volume | ||
| 6.9¢ | 7.1¢ | 6.8¢ | 7149293 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| IMU (ASX) Chart |